ChemicalsMid capRs 6,865 crRs 16.6 cr traded a day
Close on 2026-08-21
760.90
−0.33%
52-week range0% of the way up
760.901,256.00
Market cap
6,865 cr
P/E (TTM)
11.8×
industry 36×
EPS (TTM)
64.62
Revenue YoY
+36.8%
Q1 FY27
Profit YoY
+223.0%
Net margin
8.2%
+4.7pt vs a year ago
Growth trend
-20.6pt
vs last quarter’s YoY
1 month
-12.4%
Below 52w high
65.1%
RSI (14)
16
oversold
Daily swing
2.4%
average true range
Volume
1.1×
vs 20-day average
Traded
Rs 17 cr
median day
Close200-day averageMaterial filing
260 sessions · hover for the filing behind a move
1 week
−3.24%
1 month
−12.40%
3 months
−21.22%
6 months
−35.46%
1 year
−25.66%
The read
written from the numbers on this page
The evidence leans constructive5 supporting, 3 against, 1 worth knowing
Supporting
matches near a 52-week low, which has beaten the market by +0.45 points over 20 sessions across 47,393 past signals
3 independent kinds of evidence agree today, which is uncommon
revenue grew 37% year on year in the quarter ending 2026-06-30
net margin has widened from 3.4% to 8.2% across four quarters
priced at 12× earnings against an industry median of 36× — 67% below its peers
Against
trading 19% below its 200-day average
at 0% of its 52-week range — nearly everyone who bought in the past year is underwater
down 26% over twelve months
Worth knowing
RSI at 16 is washed out — historically the better half of this site's measured edge comes from exactly this condition
What would change this read: a close back above 944, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
read from the filings, with the figure behind every line
Working3
Net profit +107.5% year on year, Rs 42 cr to Rs 88 cr.
+107.5%Rs 42 crRs 88 cr
Profit grew faster than revenue, +107.5% against +38.2%.
+107.5%+38.2%
Revenue +38.2% year on year, Rs 777 cr to Rs 1,074 cr.
+38.2%Rs 777 crRs 1,074 cr
Needs watching1
Agrochemicals is 85% of revenue, so the business rests on one segment.
Agrochemicals85%
Every figure here is computed from the company’s own filings. The wording is generated directly from the figures.
How it has performed
price return over each window, measured against zero
What the scans say today
9 of 47 matched on 2026-08-21
SHARDACROP matches 9 of the 47 scans today, across 3 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
segments and revenue mix, as the company reports them
SHARDACROP reports 2 business segments. The largest is Agrochemicals at 85% of revenue in the quarter ending 2026-06-30. On these numbers this is effectively a single-segment business, so the group result and that segment’s result move together.
SegmentRevenueSharevs a year ago
Agrochemicals915 cr85.2%—
Non-agrochemicals159 cr14.8%—
Segment names are the company’s own, taken verbatim from the reportable-segment disclosure in its quarterly XBRL filing. Nothing on this page describes the business in words we wrote.
Quality of the business
balance sheet as at 2026-03-31
Return on equity
18.6%
trailing profit over shareholders’ funds
Return on capital
24.4%
pre-tax profit over equity plus borrowings
Debt to equity
0.00×
0 cr borrowed against 3,136 cr of equity
Net debt
220 cr
cash exceeds borrowings
Cash conversion
112%
operating cash flow as a share of profit
Receivable days
163
how long customers take to pay
Return on capital uses profit before tax over equity plus borrowings. The textbook version adds finance costs back; those are not tagged reliably in quarterly filings, so this understates the ratio for a heavily borrowed company rather than flattering it. Balance sheets are filed half-yearly, so these can be up to six months behind the profit figures above.
Valuation against its own history
500 sessions since 2024-09-06
15×
median 31×
42×
now 12×
SHARDACROP trades at 12× trailing earnings, below its median of 31× over this window — 62% less expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
AGM / EGM filings were typically +0.00pt vs the market over the next 5 sessions (n=4,362) · Dividend filings were typically -0.09pt vs the market over the next 5 sessions (n=634) · Analyst call filings were typically +0.14pt vs the market over the next 5 sessions (n=3,352)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 37% against the same quarter a year earlier
profit rose 223% year on year
revenue rose in 3 of the last 4 quarters
Going against it
net margin narrowed from 15.4% to 8.2%
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
2026-06-30 · consolidated
1,074
118
88
9.76
8.2%
Q4 FY26
2026-03-31 · consolidated
2,065
422
319
35.32
15.4%
Q3 FY26
2025-12-31 · consolidated
1,289
179
145
16.09
11.3%
Q3 FY25
2024-12-31 · consolidated
929
46
31
3.45
3.4%
Q2 FY25
2024-09-30 · consolidated
777
46
42
4.70
5.5%
Q1 FY25
2024-06-30 · consolidated
785
31
27
3.02
3.5%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average-11.7%
Versus 200-day average-19.4%
Below 52-week high-39.4%
Above 52-week low+0.0%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)15.9
Higher closes in last 51 of 5
Six-month return−35.46%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)2.38%
Volume versus 20-day1.1x
Median daily turnoverRs 16.6 cr
Peers
Chemicals · 44 classified companies
SHARDACROP trades at 11.8× trailing earnings against an industry median of 36.0× across 41 other classified companies in its industry — cheaper than them, by 67%. A multiple is a statement about expectations, not about quality: cheap usually means the market expects less, and it is often right.
largest twelve by market capitalisation. Market cap and P/E need filed financials, so blanks are companies whose filings have not been read yet
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.